Literature DB >> 35082033

The avermectin/milbemycin receptors of parasitic nematodes.

Adrian J Wolstenholme1, Cedric Neveu2.   

Abstract

Glutamate-gated chloride channels are the most important target of ivermectin and related compounds in parasitic nematodes. A small family of genes encode subunits of these channels, allowing the assembly of multiple channel subtypes; the subunit composition of most of the native receptors is unknown. The members of the gene family vary between species, making extrapolation from C. elegans to parasites difficult. Expression of recombinant receptors in Xenopus oocytes can identify subunits that have the ability to co-assemble into novel channels, but localisation data, ideally at the single-cell level, is required to confirm that these subunits are expressed in the same cells and tissues. Fortunately, recent advances in this area are starting to make this information available; this information is adding to our understanding of how the drugs act and of the possible subunit combinations that create their targets in vivo.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anthelmintic; Glutamate; Ivermectin; Macrocyclic lactones; Nematode

Mesh:

Substances:

Year:  2021        PMID: 35082033     DOI: 10.1016/j.pestbp.2021.105010

Source DB:  PubMed          Journal:  Pestic Biochem Physiol        ISSN: 0048-3575            Impact factor:   3.963


  2 in total

1.  Whole-genome sequencing and analysis of Streptomyces strains producing multiple antinematode drugs.

Authors:  Jeong Sang Yi; Jung Min Kim; Min-Kyoung Kang; Jong Hoon Kim; Hang Su Cho; Yeon Hee Ban; Myoung Chong Song; Kwang-Hee Son; Yeo Joon Yoon
Journal:  BMC Genomics       Date:  2022-08-23       Impact factor: 4.547

Review 2.  Assessment of Avermectins-Induced Toxicity in Animals.

Authors:  Muhammad Salman; Rao Zahid Abbas; Khalid Mehmood; Riaz Hussain; Sehar Shah; Mehwish Faheem; Tean Zaheer; Asghar Abbas; Bernardo Morales; Ina Aneva; José L Martínez
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.